Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2014-12-19

Mysimba recommended for approval in weight management in adults

View source ↗

Summary

The EMA recommended approval of Mysimba (naltrexone/bupropion) for weight management in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mysimba (naltrexone/bupropion)